ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
9 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
438
|
127K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive
|
|
NZ Trader
|
44 |
11K |
7 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
44
|
11K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
317 |
82K |
1 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
317
|
82K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
317 |
82K |
0 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
317
|
82K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric receives $1.5 M advance on FY24 R&D tax incentive
|
|
NZ Trader
|
44 |
11K |
5 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
44
|
11K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
317 |
82K |
12 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
317
|
82K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: OLE Study update reveals impressive Survival Data
|
|
NZ Trader
|
248 |
69K |
17 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
248
|
69K
|
17
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
317 |
82K |
6 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
317
|
82K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
14 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
438
|
127K
|
14
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric partnering with Cell Therapies Australia
|
|
NZ Trader
|
16 |
4.5K |
6 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
16
|
4.5K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
317 |
82K |
4 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
317
|
82K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
6.2K |
7 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
21
|
6.2K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
10 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
438
|
127K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
317 |
82K |
4 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
317
|
82K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
9 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
438
|
127K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
3 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
438
|
127K
|
3
|
|
ASX - By Stock
|
KRM |
Re:
KRM Chart
|
|
NZ Trader
|
1.5K |
355K |
1 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
1.5K
|
355K
|
1
|
|
ASX - By Stock
|
KRM |
Re:
KRM Chart
|
|
NZ Trader
|
1.5K |
355K |
1 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
1.5K
|
355K
|
1
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Kingsrose Commences Drilling at Rana Project
|
|
NZ Trader
|
1 |
837 |
1 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
1
|
837
|
1
|
|
ASX - By Stock
|
NTI |
Re:
Ann: Neurotech Global Partnering and Registration Strategy
|
|
NZ Trader
|
7 |
2.2K |
6 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
7
|
2.2K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
13 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
438
|
127K
|
13
|
|
ASX - By Stock
|
KRM |
Re:
KRM Chart
|
|
NZ Trader
|
1.5K |
355K |
2 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
1.5K
|
355K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Complete headline results for Commercial Deal, when?
|
|
NZ Trader
|
317 |
82K |
11 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
317
|
82K
|
11
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
6.2K |
11 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
21
|
6.2K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric partnering with Cell Therapies Australia
|
|
NZ Trader
|
16 |
4.5K |
4 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
16
|
4.5K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
16 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
438
|
127K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
11 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
438
|
127K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
7 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
438
|
127K
|
7
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
6.2K |
14 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
21
|
6.2K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
17 |
09/08/24 |
09/08/24 |
ASX - By Stock
|
438
|
127K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
7 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
438
|
127K
|
7
|
|
ASX - By Stock
|
SNT |
Re:
Ann: German MDS group awarded $2.5m grant for phase 2 MDS trial
|
|
NZ Trader
|
4 |
1.3K |
10 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
4
|
1.3K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Latest MND Webinar information on Monepantel
|
|
NZ Trader
|
33 |
8.7K |
10 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
33
|
8.7K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
13 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
438
|
127K
|
13
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
6.2K |
16 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
21
|
6.2K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Latest MND Webinar information on Monepantel
|
|
NZ Trader
|
33 |
8.7K |
25 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
33
|
8.7K
|
25
|
|
ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
NZ Trader
|
117 |
31K |
6 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
117
|
31K
|
6
|
|
ASX - By Stock
|
KRM |
Re:
Ann: KRM receives Exploration Permit for Drilling Penikat Project
|
|
NZ Trader
|
67 |
19K |
1 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
67
|
19K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
159 |
39K |
6 |
07/08/24 |
07/08/24 |
ASX - By Stock
|
159
|
39K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
17 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
438
|
127K
|
17
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Application for quotation of securities - CHM
|
|
NZ Trader
|
25 |
6.7K |
11 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
25
|
6.7K
|
11
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Phase 2 blood cancer trial fully recruited
|
|
NZ Trader
|
21 |
6.2K |
10 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
21
|
6.2K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
NZ Trader
|
438 |
127K |
78 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
438
|
127K
|
78
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Application for quotation of securities - CHM
|
|
NZ Trader
|
25 |
6.7K |
8 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
25
|
6.7K
|
8
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
73 |
17K |
1 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
73
|
17K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
73 |
17K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
73
|
17K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
NZ Trader
|
978 |
274K |
16 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
978
|
274K
|
16
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Application for quotation of securities - CHM
|
|
NZ Trader
|
25 |
6.7K |
7 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
25
|
6.7K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
NZ Trader
|
159 |
39K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
159
|
39K
|
2
|
|
ASX - By Stock
|
KRM |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZ Trader
|
22 |
6.0K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
22
|
6.0K
|
2
|
|